| TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial RG Everson, W Hugo, L Sun, J Antonios, A Lee, L Ding, M Bu, S Khattab, ... nature communications 15 (1), 3882, 2024 | 6 | 2024 |
| Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study G Wan, W Chen, S Khattab, K Roster, N Nguyen, B Yan, A Rajeh, J Seo, ... The Lancet Oncology 25 (8), 1053-1069, 2024 | 3 | 2024 |
| Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study G Wan, S Khattab, BW Leung, S Zhang, N Nguyen, M Tran, C Lin, ... British Journal of Dermatology, ljae053, 2024 | 2 | 2024 |
| Atim-39. Improved survival noted in glioblastoma patients treated with adjuvant tlr-3 agonist in setting of autologous lysate-pulsed dc vaccination J Antonios, R Everson, H Soto, S Khattab, J Bethel, M Sun, A Mochizuki, ... Neuro-oncology 20 (Suppl 6), vi10, 2018 | 2 | 2018 |
| SpatialCells: automated profiling of tumor microenvironments with spatially resolved multiplexed single-cell data G Wan, Z Maliga, B Yan, T Vallius, Y Shi, S Khattab, C Chang, AJ Nirmal, ... Briefings in Bioinformatics 25 (3), bbae189, 2024 | 1 | 2024 |
| Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients RG Everson, W Hugo, L Sun, J Antonios, A Lee, L Ding, M Bu, S Khattab, ... Research Square, 2023 | 1 | 2023 |
| Adjuvant TLR-3 administration enhances proinflammatory immune responses and is associated with extended survival in glioblastoma patients treated with dendritic cell vaccination. JP Antonios, RG Everson, A Mochizuki, S Khattab, H Soto, P Romiyo, ... CANCER IMMUNOLOGY RESEARCH 8 (3), 30-30, 2020 | 1 | 2020 |
| Cutaneous Imaging Techniques SY Khattab, BA Hijaz, YR Semenov Hematology/Oncology Clinics 38 (5), 907-919, 2024 | | 2024 |
| 53307 Immune Checkpoint Inhibitor Antibody Type Influences on the Development of Cutaneous Immune-Related Adverse Events and Rash Morphology S Khattab, K Roster, A Rajeh, N Nguyen, K Tang, S Zhang, H Rashdan, ... Journal of the American Academy of Dermatology 91 (3), AB51, 2024 | | 2024 |
| 50938 Risk factors and prognostication of thin melanomas E Beagles, S Khattab, N Nguyen, C Chang, K Roster, H Rashdan, B Yan, ... Journal of the American Academy of Dermatology 91 (3), AB5, 2024 | | 2024 |
| 613 Factors associated with mucosal melanoma outcomes: A multi-institutional experience S Khattab, E Beagles, M Tran, C Moseley, G Wan, CT Chang, N Nguyen, ... Journal of Investigative Dermatology 144 (8), S107, 2024 | | 2024 |
| 784 Type 2 immunity links eczematous and lichenoid eruptions caused by immune checkpoint inhibitor therapy M Azin, A McGarry, B Leung, K Roster, H Rashdan, A Rajeh, S Khattab, ... Journal of Investigative Dermatology 144 (8), S137, 2024 | | 2024 |
| 636 Importance of classical melanoma prognostic factors in the setting of acral lentiginous melanomas: A multi-institutional cohort study C Moseley, CT Chang, E Beagles, S Khattab, A Mahajan, D McDaniel, ... Journal of Investigative Dermatology 144 (8), S110, 2024 | | 2024 |
| 595 Revisiting the definition of acral melanomas: Unraveling histology and location E Beagles, S Khattab, A Mahajan, D McDaniel, S Xu, C Thang, C Moseley, ... Journal of Investigative Dermatology 144 (8), S104, 2024 | | 2024 |
| 208 Dupilumab for managing cutaneous immunotherapy toxicities does not impact mortality S Khattab, G Wan, B Leung, C Lin, M Tran, S Xu, E Beagles, C Moseley, ... Journal of Investigative Dermatology 144 (8), S36, 2024 | | 2024 |
| 033 Thromboembolic risk in dermatomyositis patients treated with intravenous immunoglobulin CT Chang, S Khattab, K Shaw, K Tang, R Vleugels, Y Semenov Journal of Investigative Dermatology 144 (8), S6, 2024 | | 2024 |
| Pass-Efficient Algorithms for Graph Spectral Clustering (Student Abstract) B Yan, G Wan, H Schweitzer, Z Maliga, S Khattab, KH Yu, PK Sorger, ... Proceedings of the AAAI Conference on Artificial Intelligence 38 (21), 23690 …, 2024 | | 2024 |
| Individualized melanoma risk prediction using machine learning with electronic health records G Wan, S Khattab, K Roster, N Nguyen, B Yan, H Rashdan, H Estiri, ... medRxiv, 2024.07. 26.24311080, 2024 | | 2024 |
| Checkpoint inhibitor antibody type influences the development of cutaneous immune-related adverse events: A multi-institutional study K Roster, A Rajeh, N Nguyen, K Tang, S Zhang, H Rashdan, G Wan, ... Journal of the American Academy of Dermatology 90 (1), 189-192, 2024 | | 2024 |
| CTIM-18. DENDRITIC CELL VACCINATION IN CONJUNCTION WITH ADJUVANT TLR-3 AGONIST ADMINISTRATION ENHANCES PRO-INFLAMMATORY IMMUNE RESPONSES AND IS ASSOCIATED WITH EXTENDED … C Chavez, R Everson, J Orpilla, A Lee, S Khattab, J Antonios, A Salazar, ... Neuro-Oncology 22 (Suppl 2), ii36, 2020 | | 2020 |
